Cyclerion Announces Leadership Transitions
Cheryl Gault promoted to Chief Operating Officer Amy Schulman stepping down from Board of Directors CAMBRIDGE, Mass., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company developing innovative medicines for people with serious diseases of the central nervous system (CNS), today announced, effective January 1, 2021, the promotions of Cheryl Gault to Chief Operating Officer and Anjeza Gjino to Chief Financial Officer. Bill Huy...
Source: globenewswire.com